Not surprisingly, Google searches for anxiety and panic attack symptoms hit an all-time high during the beginning of the pandemic from mid-March to mid-May. (CNN)
In England, psychiatrists are asking the government to waive fines for parents refusing to send their kids back to school this fall, as many children are experiencing significant anxiety over returning. (The Guardian)
But in related news, pandemic-related isolation may magnify or cause relapse of many eating disorders. (Scientific American)
Adolescents treated with escitalopram (Lexapro) for 8 weeks saw a significant improvement in the Pediatric Anxiety Rating Scale, but the CYP2C19 phenotype mediated escitalopram pharmacokinetics. (Journal of Clinical Psychiatry)
An FDA advisory committee is slated to review the new drug application of Alkermes’ oral atypical antipsychotic drug ALKS 3831 — combination olanzapine/samidorphan — for the treatment of adults with schizophrenia or bipolar I disorder, this October.
People who suffered from depression or anxiety during their teens may hold a 20% higher chance of having a heart attack by midlife, according to research to be presented at the upcoming 2020 European Society of Cardiology Congress. Look for MedPage Today‘s coverage of the virtual meeting here. (ScienceDaily)
Adolescents struggling with anorexia may experience stunted growth as a result. “Our findings emphasize the importance of early and intensive intervention aiming at normalization of body weight, which may result in improved growth and allow patients to reach their full height potential,” said Dalit Modan-Moses, MD, of Chaim Sheba Medical Center in Israel. (Journal of Clinical Endocrinology & Metabolism)
Essential Pharma announced it is discontinuing manufacturing of its Priadel brand of lithium carbonate — the standard first-line treatment for bipolar disorder — prompting concerns in Britain about a drug shortage with consequent risks for patients’ relapse and possible hospitalization. (The Pharmaceutical Journal)